US 7868160
Compositions and methods for inhibiting expression of anti-apoptotic genes
granted A61PA61P1/18A61P31/00
Quick answer
US patent 7868160 (Compositions and methods for inhibiting expression of anti-apoptotic genes) held by Alnylam Pharmaceuticals, Inc. expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P1/18, A61P31/00, A61P35/00